

Consumer healthcare product developer Futura Medical is in talks with a major pharmaceutical company on a licensing deal for its pain relief product, ...


Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acne...


Futura Medical said a number of potential improvements to the production process of its ‘erectogenic’ condom have been identified by Durex condom make...


The market liked Lifeline Scientific's maiden interim operating profit of $73,000 versus last year's loss of $3.1m, as the sale of 11 new LifePort kid...


Jewellery maker Abbeycrest said it is performing in line with expectations as it undergoes a turnaround plan. The unbranded jewellery business is del...


Banking software firm Intelligent Environments said trading in the current year to date has been robust. The group said it has experienced strong dema...


Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for t...